Literature DB >> 33909253

Diphenyl diselenide alone and in combination with itraconazole against Sporothrix schenckii s.str. and Sporothrix globosa.

Vanice Rodrigues Poester1, Lívia Silveira Munhoz1, Cristina Wayne Nogueira2, Gilson Rogério Zeni2, David A Stevens3,4, Melissa Orzechowski Xavier5.   

Abstract

We evaluated the in vitro susceptibility of Sporothrix schenckii s.str. and Sporothrix globosa to diphenyl diselenide (PhSe)2 alone and in association with itraconazole (ITZ). Eight clinical isolates were tested in microdilution and checkerboard assays. (PhSe)2 alone inhibited all isolates in concentration ≤ 8 µg/mL and was effective in killing one S. schenckii isolate. Inhibitory and fungicidal beneficial effects in its interaction with ITZ were shown against 87.5% (7/8) and 50% (4/8) of the isolates tested, respectively. Our study demonstrates the in vitro antifungal activity of (PhSe)2 against two pathogenic Sporothrix species, suggesting studies of in vivo applications are warranted.
© 2021. Sociedade Brasileira de Microbiologia.

Entities:  

Keywords:  Antifungal activity; Organoselenium compound; Sporotrichosis; Subcutaneous mycoses

Mesh:

Substances:

Year:  2021        PMID: 33909253      PMCID: PMC8324665          DOI: 10.1007/s42770-021-00506-2

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  17 in total

1.  Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.

Authors:  A Espinel-Ingroff; D P B Abreu; R Almeida-Paes; R S N Brilhante; A Chakrabarti; A Chowdhary; F Hagen; S Córdoba; G M Gonzalez; N P Govender; J Guarro; E M Johnson; S E Kidd; S A Pereira; A M Rodrigues; S Rozental; M W Szeszs; R Ballesté Alaniz; A Bonifaz; L X Bonfietti; L P Borba-Santos; J Capilla; A L Colombo; M Dolande; M G Isla; M S C Melhem; A C Mesa-Arango; M M E Oliveira; M M Panizo; Z Pires de Camargo; R M Zancope-Oliveira; J F Meis; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

2.  Treatment of cutaneous sporotrichosis with itraconazole--study of 645 patients.

Authors:  Mônica Bastos de Lima Barros; Armando Oliveira Schubach; Raquel de Vasconcellos Carvalhaes de Oliveira; Ezequias Batista Martins; José Liporage Teixeira; Bodo Wanke
Journal:  Clin Infect Dis       Date:  2011-06-15       Impact factor: 9.079

Review 3.  Global epidemiology of sporotrichosis.

Authors:  Arunaloke Chakrabarti; Alexandro Bonifaz; Maria Clara Gutierrez-Galhardo; Takashi Mochizuki; Shanshan Li
Journal:  Med Mycol       Date:  2014-12-19       Impact factor: 4.076

Review 4.  Origin and distribution of Sporothrix globosa causing sapronoses in Asia.

Authors:  Tarek A A Moussa; Naif M S Kadasa; Hassan S Al Zahrani; Sarah Abdallah Ahmed; Peiying Feng; Albertus H G Gerrits van den Ende; Yu Zhang; Rui Kano; Fuqiu Li; Shanshan Li; Yang Song; Bilin Dong; Luana Rossato; Somayeh Dolatabadi; Sybren de Hoog
Journal:  J Med Microbiol       Date:  2017-05-22       Impact factor: 2.472

5.  Biosynthesis and functions of melanin in Sporothrix schenckii.

Authors:  R Romero-Martinez; M Wheeler; A Guerrero-Plata; G Rico; H Torres-Guerrero
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Interference of melanin in the susceptibility profile of Sporothrix species to amphotericin B.

Authors:  Débora Alves Nunes Mario; Roberto Christ Vianna Santos; Laura Bedin Denardi; Rodrigo de Almeida Vaucher; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Rev Iberoam Micol       Date:  2015-06-09       Impact factor: 1.044

7.  2,2'-Dithienyl diselenide pro-oxidant activity accounts for antibacterial and antifungal activities.

Authors:  Ana Paula Pesarico; Gláubia Sartori; Camilla F A dos Santos; José S S Neto; Vandreza Bortolotto; Roberto Christ Vianna Santos; Cristina W Nogueira; Marina Prigol
Journal:  Microbiol Res       Date:  2013-05-14       Impact factor: 5.415

8.  Atypical Clinical Presentation of Sporotrichosis Caused by Sporothrix globosa Resistant to Itraconazole.

Authors:  Olga Fischman Gompertz; Anderson M Rodrigues; Geisa F Fernandes; Henri D L Bentubo; Zoilo Pires de Camargo; Valéria Petri
Journal:  Am J Trop Med Hyg       Date:  2016-04-25       Impact factor: 2.345

9.  Molecular Diagnosis of Pathogenic Sporothrix Species.

Authors:  Anderson Messias Rodrigues; G Sybren de Hoog; Zoilo Pires de Camargo
Journal:  PLoS Negl Trop Dis       Date:  2015-12-01

10.  Sporotrichosis by Sporothrix schenckii senso stricto with itraconazole resistance and terbinafine sensitivity observed in vitro and in vivo: Case report.

Authors:  Rodrigo Vettorato; Daiane Heidrich; Fernanda Fraga; Amanda Carvalho Ribeiro; Danielle Machado Pagani; Carina Timotheo; Tais Guarienti Amaro; Gerson Vettorato; Maria Lúcia Scroferneker
Journal:  Med Mycol Case Rep       Date:  2017-10-28
View more
  1 in total

1.  Treatment of Human Sporotrichosis Caused by Sporothrix brasiliensis.

Authors:  Vanice Rodrigues Poester; Rossana Patricia Basso; David A Stevens; Lívia Silveira Munhoz; Vanessa Brito de Souza Rabello; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira; Mariza Zanchi; Jéssica Louise Benelli; Melissa Orzechowski Xavier
Journal:  J Fungi (Basel)       Date:  2022-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.